Form 4 for ANIX Anixa Biosciences Inc
Accepted 2025-01-23 00:00:00 ET · period of report 2025-01-22 · accession 0001493152-25-003330 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-23 | 2025-01-22 | ANIX | Titterton Lewis H jr | Dir | P - Purchase | $3.01 | +2,000 | 930.3K | +0.2% | +$6,020 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-22 | P | A | 2,000 | $3.01 | 930,334 | D | — | — |